From: Could vertigo be a post-COVID-19 sequela or presenting symptom?
 | Post-Covid-19 patients (n = 7) | Close contacts (n = 37) |
---|---|---|
Demographic data | ||
  Age (years) Mean ± SD | 49.8 ± 13.9 | 52.2 ± 13 |
  Sex (Male: Female) | 1 (14.3%):6 (85.7%) | 21(56.8%): 16(43.2%) |
Clinical presentation | ||
  Positional vertigo | 1 (14.3%) | 16 (43.2%) |
  Balance difficulties | 6 (85.7%) | 21 (56.8%) |
Laboratory data | Â | Â |
 Serum ferritin |  |  |
  Normal | 7 (100%) | 33 (89.2%) |
  Elevated | – | 4 (10.8%) |
 CBC |  |  |
  Normal | 7 (100%) | 27 (73%) |
  Leucopenia | – | 1 (2.7%) |
  Lymphopenia | – | 6 (16.2%) |
  Lymphopenia and Leucopenia | – | 1 (2.7%) |
  Lymphopenia and Leukocytosis | – | 2 (5.4%) |
 CRP |  |  |
  Negative | 3 (42.9%) | 23 (62.2%) |
  Positive | 4 (57.1%) | 14 (37.8%) |
 Liver enzymes |  |  |
  Normal | 7 (100%) | 33 (89.2%) |
  Elevated | – | 4 (10.8%) |
 CT chest at vertigo presentation |  |  |
  Normal | 6 (85.7%) | 36 (97.3%) |
  Fibrotic | 1 (14.3%) | 0 (0%) |
  GGO | 0 (0%) | 1 (2.7%) |